July 5, 2022
Hereditary factors that increase the likelihood of cancer mutations detailed in new study
The study is the result of a collaboration between IRB Barcelona and CRG. It is…
June 17, 2022
Research projects from two BIST centres receive €14 M in funding from the European Union
This month, two projects from two BIST centres received a total of €14 M in…
June 3, 2022
Not individual genes but the “mutational signatures” of many genes hold the key to better cancer therapies
As an approach to personalised medicine, a new study by researchers from the BIST centre…
May 23, 2022
Scientists disclose the mechanism of action of solnatide, a possible treatment for pulmonary edema
Solnatide is a synthetic peptide currently undergoing clinical trials for the treatment of life-threatening lung…
May 3, 2022
MCLA-158, first clinical candidate screened in organoids targeting cancer stem cells of solid tumours
An international consortium, led by the BIST centre IRB Barcelona and the biotechnology company Merus,…
